Correction: The Synergistic Inhibition of Coronavirus Replication and Induced Cytokine Production by Ciclesonide and the Tylophorine-Based Compound Dbq33b (Pharmaceutics, (2022), 14, (1511), 10.3390/pharmaceutics14071511)

Yue Zhi Lee, Hsing Yu Hsu, Cheng Wei Yang, Yi Ling Lin, Sui Yuan Chang, Ruey Bing Yang, Jian Jong Liang, Tai Ling Chao, Chun Che Liao, Han Chieh Kao, Jang Yang Chang, Huey Kang Sytwu, Chiung Tong Chen, Shiow Ju Lee

Research output: Contribution to journalComment/debatepeer-review

Abstract

Changes to “authors who contributed equally” In the original publication [1], the authors who had “contributed equally” were not listed. The corrected statement appears here. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Original languageEnglish
Article number342
JournalPharmaceutics
Volume15
Issue number2
DOIs
Publication statusPublished - Feb 2023
Externally publishedYes

ASJC Scopus subject areas

  • Pharmaceutical Science

Fingerprint

Dive into the research topics of 'Correction: The Synergistic Inhibition of Coronavirus Replication and Induced Cytokine Production by Ciclesonide and the Tylophorine-Based Compound Dbq33b (Pharmaceutics, (2022), 14, (1511), 10.3390/pharmaceutics14071511)'. Together they form a unique fingerprint.

Cite this